The BAD news -
Four IPOs fail to price
Breast implant maker GC Aesthetics (GCAA) did not price as scheduled, but will assess its IPO on a day-to-day basis. Citing pressure on energy investors and implying valuation pushback, Carlyle-backed Philadelphia Energy Solutions (PESC), the third-largest IPO of the week, postponed as well. Benitec Biopharma (BNTC) postponed its IPO, likely reflecting its early stage and a lack of in-human efficacy data. RiverBanc Multifamily Investors (RMI), originally on the IPO calendar for last week, has officially postponed its IPO, possibly reflecting valuation sensitivity.
The GOOD news -
So far this year, 127 companies have come public, and the average first-day pop has been about 16%. In the past two weeks, 8 of 12 IPOs ended their first day down or flat. The downward trend accelerated this week with an average first-day return of just 6%. Three biotech companies had successful IPOs and averaged 22% returns on the first day, but two consumer companies and one energy company launched with an average first-day return of -11%. The average return was 16% in a week that saw the Nasdaq fall 2%.
http://www.renaissancecapital.com/news/us-ipo-weekly-recap:-a-bad-week-besides-biotech-34855.html
- Forums
- ASX - By Stock
- BLT
- Renaissance Capital BLT Update
Renaissance Capital BLT Update
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online